Literature DB >> 23873737

Thiuram disulfides as pseudo-irreversible inhibitors of lymphoid tyrosine phosphatase.

Rhushikesh A Kulkarni1, Stephanie M Stanford, Nadeem A Vellore, Divya Krishnamurthy, Matthew R Bliss, Riccardo Baron, Nunzio Bottini, Amy M Barrios.   

Abstract

We screened a small library of thiuram disulfides for inhibition of lymphoid tyrosine phosphatase (LYP) activity. The parent thiuram disulfide, disulfiram, inhibited LYP activity in vitro and in Jurkat T cells, whereas diethyldithiocarbamate failed to inhibit LYP at the concentrations tested. Compound 13, an N-(2-thioxothiazolidin-4-one) analogue, was found to be the most potent LYP inhibitor in this series, with an IC50 value of 3 μM. Compound 13 inhibits LYP pseudo-irreversibly, as evidenced by the time-dependence of inhibition, with a K(i) value of 1.1 μM and a k(inact) value of 0.004 s⁻¹. The inhibition of LYP by compound 13 could not be reversed significantly by incubation with glutathione or by prolonged dialysis, but could be partially reversed by incubation with dithiothreitol. Compound 13 also inhibited LYP activity in Jurkat T cells.
Copyright © 2013 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  PTP; disulfiram; inhibitors; screening; thiuram disulfides

Mesh:

Substances:

Year:  2013        PMID: 23873737      PMCID: PMC3863632          DOI: 10.1002/cmdc.201300215

Source DB:  PubMed          Journal:  ChemMedChem        ISSN: 1860-7179            Impact factor:   3.466


  36 in total

1.  Gold(I)-mediated inhibition of protein tyrosine phosphatases: a detailed in vitro and cellular study.

Authors:  Divya Krishnamurthy; Mark R Karver; Edoardo Fiorillo; Valeria Orrú; Stephanie M Stanford; Nunzio Bottini; Amy M Barrios
Journal:  J Med Chem       Date:  2008-07-08       Impact factor: 7.446

2.  Redox modifications of protein-thiols: emerging roles in cell signaling.

Authors:  Saibal Biswas; Asiya Seema Chida; Irfan Rahman
Journal:  Biochem Pharmacol       Date:  2005-12-06       Impact factor: 5.858

Review 3.  PEST family phosphatases in immunity, autoimmunity, and autoinflammatory disorders.

Authors:  André Veillette; Inmoo Rhee; Cleiton Martins Souza; Dominique Davidson
Journal:  Immunol Rev       Date:  2009-03       Impact factor: 12.988

4.  A loss-of-function variant of PTPN22 is associated with reduced risk of systemic lupus erythematosus.

Authors:  Valeria Orrú; Sophia J Tsai; Blanca Rueda; Edoardo Fiorillo; Stephanie M Stanford; Jhimli Dasgupta; Jaana Hartiala; Lei Zhao; Norberto Ortego-Centeno; Sandra D'Alfonso; Frank C Arnett; Hui Wu; Miguel A Gonzalez-Gay; Betty P Tsao; Bernardo Pons-Estel; Marta E Alarcon-Riquelme; Yantao He; Zhong-Yin Zhang; Hooman Allayee; Xiaojiang S Chen; Javier Martin; Nunzio Bottini
Journal:  Hum Mol Genet       Date:  2008-11-03       Impact factor: 6.150

5.  High-throughput cell-based screening of 4910 known drugs and drug-like small molecules identifies disulfiram as an inhibitor of prostate cancer cell growth.

Authors:  Kristiina Iljin; Kirsi Ketola; Paula Vainio; Pasi Halonen; Pekka Kohonen; Vidal Fey; Roland C Grafström; Merja Perälä; Olli Kallioniemi
Journal:  Clin Cancer Res       Date:  2009-09-29       Impact factor: 12.531

6.  Aryl vinyl sulfonates and sulfones as active site-directed and mechanism-based probes for protein tyrosine phosphatases.

Authors:  Sijiu Liu; Bo Zhou; Heyi Yang; Yantao He; Zhong-Xing Jiang; Sanjai Kumar; Li Wu; Zhong-Yin Zhang
Journal:  J Am Chem Soc       Date:  2008-06-04       Impact factor: 15.419

7.  Crystal structure of the human lymphoid tyrosine phosphatase catalytic domain: insights into redox regulation .

Authors:  Sophia J Tsai; Udayaditya Sen; Lei Zhao; William B Greenleaf; Jhimli Dasgupta; Edoardo Fiorillo; Valeria Orrú; Nunzio Bottini; Xiaojiang S Chen
Journal:  Biochemistry       Date:  2009-06-09       Impact factor: 3.162

8.  Discovery of a novel submicromolar inhibitor of the lymphoid specific tyrosine phosphatase.

Authors:  Yuli Xie; Yidong Liu; Gangli Gong; Alison Rinderspacher; Shi-Xian Deng; Deborah H Smith; Udo Toebben; Effie Tzilianos; Lars Branden; Dusica Vidović; Caty Chung; Stephan Schürer; Lutz Tautz; Donald W Landry
Journal:  Bioorg Med Chem Lett       Date:  2008-04-08       Impact factor: 2.823

Review 9.  Protein tyrosine phosphatases in autoimmunity.

Authors:  Torkel Vang; Ana V Miletic; Yutaka Arimura; Lutz Tautz; Robert C Rickert; Tomas Mustelin
Journal:  Annu Rev Immunol       Date:  2008       Impact factor: 28.527

10.  Autoimmune-associated lymphoid tyrosine phosphatase is a gain-of-function variant.

Authors:  Torkel Vang; Mauro Congia; Maria Doloretta Macis; Lucia Musumeci; Valeria Orrú; Patrizia Zavattari; Konstantina Nika; Lutz Tautz; Kjetil Taskén; Francesco Cucca; Tomas Mustelin; Nunzio Bottini
Journal:  Nat Genet       Date:  2005-11-06       Impact factor: 38.330

View more
  2 in total

1.  Covalent inhibition of the lymphoid tyrosine phosphatase.

Authors:  Vanessa F Ahmed; Nunzio Bottini; Amy M Barrios
Journal:  ChemMedChem       Date:  2014-01-08       Impact factor: 3.466

Review 2.  Interrogating Protein Phosphatases with Chemical Activity Probes.

Authors:  Garrett R Casey; Cliff I Stains
Journal:  Chemistry       Date:  2018-03-08       Impact factor: 5.236

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.